Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.41 -0.07 (-2.62%)
As of: Nov 12, 2026 · 2:13 PM EST

Rocket Pharmaceuticals (RCKT) Sales of Property, Plant and Equipment (2018)

Updated

Rocket Pharmaceuticals (RCKT) recorded Sales of Property, Plant and Equipment of $135,000 in FY2024.

Analysis

Rocket Pharmaceuticals (RCKT) Sales of Property, Plant and Equipment (2018) Analysis & Trends

  • The FY2024 figure is the lowest annual Sales of Property, Plant and Equipment since FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Rocket Pharmaceuticals 268.37 Mn -15.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 20,000.00
API Access

Rocket Pharmaceuticals Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=RCKT&period=max&api_key=YOUR_API_KEY